Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast-release aspirin 650 mg for postsurgical dental pain
2014-005278-12Phase 3
- Sponsor
- Bayer
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in dental postoperative pain (3 arms), sponsored by Bayer. Primary endpoint: Time to first perceptible pain relief.
02
Drugs
aspirin
03
Conditions
dental postoperative pain
Beyond the preview
Go deeper on 2014-005278-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005278-12.